Gene Name |
SHC (Src homology 2 domain containing) transforming protein 3 |
erb-b2 receptor tyrosine kinase 3 |
Image |
No pdb structure |
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Response to statin therapy (LDL-C) ( 22331829)
|
|
Protein-Protein Interactions |
16 interactors:
ALK
APP
ARHGAP32
AXL
EGFR
ERBB2
ERBB3
FLT4
GOLGA2
GRB2
KRT31
KRT40
NTRK1
NTRK2
RET
SH3GL3
|
66 interactors:
ABL1
ABL2
AGTR2
BCAR3
CD82
CDK5
CHN2
CRK
CRKL
DAB1
DAPP1
EGF
EGFR
EGR1
ERBB2
ERBB4
FER
FGFR1
FLNA
FLYWCH1
GRB2
GRB7
HCK
HDAC6
IL6ST
ITK
JAK2
JAK3
MUC1
NCK1
NCK2
NEDD4
NRG1
NRG2
ODF2L
PA2G4
PIK3R1
PIK3R2
PIK3R3
PLCG1
PTGES3
PTK2
PTK2B
PTK6
RASA1
RASA4
RGS4
RIN1
RNF41
RPN1
SH2B3
SH2D1A
SHC1
SHC3
SOS1
SRC
SYK
TNS2
TNS3
TNS4
TXK
VAV1
VAV2
VAV3
ZAP70
ZNF207
|
Entrez ID |
53358 |
2065 |
HPRD ID |
12005 |
01820 |
Ensembl ID |
|
ENSG00000065361
|
Uniprot IDs |
Q92529
|
P21860
|
PDB IDs |
|
1M6B
2L9U
3KEX
3LMG
3P11
4LEO
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
acquire
alteration
associate
cascades
concurrent
dependence
egf
enhancing
latent
mapk
mediators
p42
p44
phosphotyrosine
potentiates
potentiating
predicts
prime
priming
progestin
progestins
r5020
shc
shift
stat5
steroid
switches
synergistically
waf1
|
Tagcloud (Difference) ? |
|
acquire
alteration
associate
cascades
concurrent
dependence
egf
enhancing
latent
mapk
mediators
p42
p44
phosphotyrosine
potentiates
potentiating
predicts
prime
priming
progestin
progestins
r5020
shc
shift
stat5
steroid
switches
synergistically
waf1
|
Tagcloud (Intersection) ? |
|